Monem

Monem

meropenem

Manufacturer:

Biolab

Distributor:

Biopharm
Concise Prescribing Info
Contents
Meropenem
Indications/Uses
Intra-abdominal, skin & skin structure infections, meningitis, UTI, gynecological infections eg, endometritis & pelvic inflammatory disease, septicaemia, pneumonias & nosocomial pneumonias. As monotherapy or combination w/ antiviral or antifungal agents in febrile neutropenia.
Dosage/Direction for Use
Adult Pneumonia, UTI, gynaecological, skin & skin structure infections 500 mg IV 8 hrly. Nosocomial pneumonias, peritonitis, infections in febrile neutropenic patients, septicemia 1 g 8 hrly. Meningitis 2 g 8 hrly. Childn >3 mth & up to 12 yr 10-20 mg/kg IV 8 hrly. >50 kg Use adult dosage. Meningitis 40 mg/kg IV 8 hrly. Renal insufficiency Dose reduction based on CrCl.
Contraindications
Hypersensitivity.
Special Precautions
Prolonged use may result in overgrowth of nonsusceptible organisms. Pseudomembranous colitis has been reported. Pregnancy & lactation.
Adverse Reactions
Local reactions at inj site. Urticaria, rash, pruritus, erythema multiforme, toxic epidermal necrolysis & Stevens-Johnson syndrome. Nausea, vomiting, abdominal pain, diarrhoea, Pseudomembranous colitis. Hematological & hepatic changes. Paraesthesiae, headache, seizures, angioedema, anaphylaxis; oral & vag candidosis.
Drug Interactions
Probenecid inhibits the renal excretion of meropenem. Valproic acid serum levels may be reduced to subtherapeutic levels.
MIMS Class
ATC Classification
J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.
Presentation/Packing
Form
Monem powd for inj 500 mg
Packing/Price
10 × 1's
Form
Monem powd for inj 1 g
Packing/Price
10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in